ECG · Mid Cap · NYSE · Industrials · Engineering & Construction
Free research brief
Free to track. No card required.
Price, momentum, and the numbers behind the story.
Overall score
74/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Current price
$120.14
Lowest
$152
Median target
$176
Highest
$200
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Price / sales
Strong · Low price-to-sales
1.40x
ROIC
Strong · Excellent capital returns
27.9%
ROE
Favorable · 39.0% - strong capital efficiency
39.5%
Debt / equity
Favorable · 0.53 - strong leverage
0.47x
Current ratio
Strong · Good liquidity position
1.59x
ECG against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $5.99B | 23.6 | +30.5% | 74 | |
| $7.28B | 25.7 | +24.0% | 77 | |
| $33.27B | 23.4 | +18.9% | 76 | |
| $56.67B | 39.6 | +46.1% | 75 | |
| $9.06B | 27.3 | +37.8% | 75 |
Every story that touched the stock this week, newest first.